ESC 365 - Closing remarks: interpreting findings with non-vitamin K antagonist (VKA) oral anticoagulants in atrial fibrillation – Collective views on data from seminal studies to present clinical practice.

Open Access

Closing remarks: interpreting findings with non-vitamin K antagonist (VKA) oral anticoagulants in atrial fibrillation – Collective views on data from seminal studies to present clinical practice.

Session: Interpreting findings with non-vitamin K antagonist (VKA) oral anticoagulants in atrial fibrillation – Collective views on data from seminal studies to present clinical practice

Topic: Atrial fibrillation (AF)

Speaker: Professor C. Bode (Freiburg im Breisgau, DE)

About the speaker

Professor Christoph Bode

Heart Center Freiburg University, Freiburg im Breisgau (Germany)

12 presentations

0 follower

4 more presentations in this session

Non-VKA oral anticoagulation in atrial fibrillation: an overview of seminal studies.

Speaker: Doctor J. Cox (Halifax, CA)

Access

Slides

Video

From large-scale study to larger-scale practice: how do real-world findings for non-VKA oral anticoagulants stack up?

Speaker: Doctor M. Patel (Durham, US) Doctor E. Peterson (Dallas, US)

Access

Slides

Video

Day-to-day management of patients with atrial fibrillation on non-VKA oral anticoagulant therapy – Practical perspectives.

Speaker: Associate Professor P. Verhamme (Leuven, BE)

Access

Slides

Video

The management of patients with atrial fibrillation and renal impairment – Practical perspectives.

Speaker: Doctor J. Cox (Halifax, CA)

Access

Slides

Video

Access the full session

Interpreting findings with non-vitamin K antagonist (VKA) oral anticoagulants in atrial fibrillation – Collective views on data from seminal studies to present clinical practice

Speakers: Professor C. Bode, Doctor J. Cox, Doctor M. Patel, Doctor E. Peterson, Associate Professor P. Verhamme...

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

Closing remarks: interpreting findings with non-vitamin K antagonist (VKA) oral anticoagulants in atrial fibrillation – Collective views on data from seminal studies to present clinical practice.

About the speaker

Professor Christoph Bode

4 more presentations in this session

Non-VKA oral anticoagulation in atrial fibrillation: an overview of seminal studies.

From large-scale study to larger-scale practice: how do real-world findings for non-VKA oral anticoagulants stack up?

Day-to-day management of patients with atrial fibrillation on non-VKA oral anticoagulant therapy – Practical perspectives.

The management of patients with atrial fibrillation and renal impairment – Practical perspectives.

Access the full session

Interpreting findings with non-vitamin K antagonist (VKA) oral anticoagulants in atrial fibrillation – Collective views on data from seminal studies to present clinical practice

About the event

ESC Congress 2016

ESC 365 is supported by